Wesley Health System LLC
Wesley Health System LLC was paid $37.82M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
HATTIESBURG, MS 39402
Next to other General Acute Care Hospital providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 153,485 | $5.52M | |
| 2019 | 146,990 | $5.97M | |
| 2020 | 117,050 | $4.46M | |
| 2021 | 139,988 | $5.70M | |
| 2022 | 168,434 | $6.18M | |
| 2023 | 159,483 | $5.90M | |
| 2024incomplete | 99,769 | $4.09M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 44,867 | 37,277 | $6.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 28,051 | 23,159 | $5.44M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6.8% | 50,717 | 9,698 | $2.59M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 12,329 | 10,011 | $2.53M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.9% | 61,791 | 10,777 | $1.87M |
| G0378 | Hospital observation service, per hour | 4.1% | 4,756 | 3,751 | $1.57M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.4% | 58,814 | 10,849 | $1.30M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 12,226 | 9,930 | $1.06M |
| D7140 | Extraction, erupted tooth or exposed root | 2.5% | 1,802 | 1,327 | $935K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.7% | 29,866 | 5,672 | $654K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 3,710 | 3,172 | $615K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 7,249 | 6,183 | $614K |
241 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.5% | 6,061 | $584K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 18,719 | $541K |
| D0272 | Bitewings - two radiographic images | 1.3% | 875 | $473K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.2% | 1,271 | $454K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 19,198 | $440K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 3,003 | $435K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 21,412 | $424K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 5,247 | $419K |
| 92526 | 1.1% | 8,312 | $418K | |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 10,308 | $404K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 11,274 | $385K |
| 93975 | 1.0% | 2,783 | $379K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 6,239 | $376K |
| 59025 | Fetal non-stress test | <1% | 3,341 | $336K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,971 | $324K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,422 | $316K |
| 97533 | <1% | 13,857 | $304K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 9,280 | $237K |
| 86900 | <1% | 4,243 | $229K | |
| 80053 | Comprehensive metabolic panel | <1% | 31,880 | $226K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,434 | $211K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,805 | $189K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,914 | $187K |
| 97116 | <1% | 12,266 | $181K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 34,020 | $163K |
| 92523 | <1% | 1,183 | $161K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 3,498 | $133K |
| 76801 | <1% | 1,953 | $129K | |
| 84484 | <1% | 15,001 | $113K | |
| 97161 | <1% | 2,883 | $105K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,722 | $105K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,489 | $104K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,482 | $100K |
| 36415 | Collection of venous blood by venipuncture | <1% | 45,413 | $100K |
| 83880 | <1% | 4,068 | $91K | |
| 93017 | <1% | 1,469 | $88K | |
| 81025 | <1% | 14,842 | $86K | |
| 73630 | <1% | 1,813 | $79K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 1,987 | $79K |
| 74018 | <1% | 1,760 | $78K | |
| 86901 | <1% | 4,241 | $71K | |
| 73610 | <1% | 1,505 | $66K | |
| 97165 | <1% | 1,638 | $66K | |
| 86850 | <1% | 2,757 | $63K | |
| 93976 | <1% | 1,091 | $61K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,361 | $61K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,361 | $60K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,175 | $58K |
| D2933 | <1% | 554 | $57K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,866 | $56K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,583 | $56K |
| 73130 | <1% | 1,247 | $56K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 544 | $51K |
| 83735 | <1% | 13,176 | $51K | |
| D1120 | Dental cleaning, child | <1% | 3,365 | $50K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,240 | $48K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 954 | $48K |
| 73030 | <1% | 1,173 | $44K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,228 | $44K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,389 | $43K |
| 80061 | Lipid panel | <1% | 4,922 | $42K |
| 87807 | <1% | 4,012 | $42K | |
| 87040 | <1% | 6,355 | $42K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,460 | $40K |
| 83690 | <1% | 8,299 | $38K | |
| 73562 | <1% | 931 | $34K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 430 | $33K |
| 84702 | <1% | 3,047 | $32K | |
| 83605 | <1% | 4,780 | $32K | |
| 93971 | <1% | 794 | $31K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 640 | $30K |
| 73110 | <1% | 717 | $30K | |
| 72100 | <1% | 607 | $30K | |
| 85027 | <1% | 7,138 | $29K | |
| 93458 | <1% | 37 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 803 | $27K |
| 93798 | <1% | 696 | $26K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 3,121 | $26K |
| 81001 | <1% | 11,726 | $25K | |
| 85730 | <1% | 7,550 | $24K | |
| 85610 | <1% | 10,225 | $24K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 221 | $21K |
| 73590 | <1% | 482 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,493 | $20K |
| 87186 | <1% | 3,348 | $20K | |
| D2934 | <1% | 288 | $20K | |
| 81003 | <1% | 12,450 | $20K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,647 | $19K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 668 | $18K |
| 87077 | <1% | 3,198 | $18K | |
| 97113 | <1% | 400 | $16K | |
| 10060 | <1% | 165 | $16K | |
| 82962 | <1% | 8,158 | $15K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 309 | $14K |
| 85379 | <1% | 2,283 | $13K | |
| 95811 | <1% | 30 | $13K | |
| 84439 | <1% | 2,321 | $12K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 29 | $12K |
| 73564 | <1% | 204 | $11K | |
| 82607 | <1% | 1,393 | $11K | |
| 93970 | <1% | 165 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 621 | $10K |
| 73080 | <1% | 237 | $10K | |
| 93880 | <1% | 167 | $10K | |
| 73090 | <1% | 206 | $9K | |
| 93925 | <1% | 158 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 169 | $9K |
| D1351 | Sealant - per tooth | <1% | 583 | $7K |
| 82550 | <1% | 1,248 | $7K | |
| 72020 | <1% | 175 | $6K | |
| 80069 | <1% | 1,263 | $6K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 69 | $6K |
| 86140 | <1% | 1,695 | $6K | |
| 87210 | <1% | 1,641 | $6K | |
| 73502 | <1% | 190 | $5K | |
| 82746 | <1% | 712 | $5K | |
| 12001 | <1% | 41 | $5K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 69 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,538 | $5K |
| 29125 | <1% | 83 | $4K | |
| 87070 | <1% | 548 | $4K | |
| 87220 | <1% | 851 | $3K | |
| 85007 | <1% | 530 | $3K | |
| 72170 | <1% | 47 | $2K | |
| 82553 | <1% | 294 | $2K | |
| 85652 | <1% | 1,386 | $2K | |
| 82728 | <1% | 307 | $2K | |
| 70496 | <1% | 30 | $2K | |
| 97166 | <1% | 42 | $2K | |
| D2330 | <1% | 91 | $2K | |
| 82077 | <1% | 187 | $2K | |
| 74230 | <1% | 55 | $2K | |
| 82565 | <1% | 539 | $2K | |
| 12011 | <1% | 13 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 84 | $1K |
| 92610 | <1% | 52 | $1K | |
| 82803 | <1% | 100 | $1K | |
| 87205 | <1% | 454 | $1K | |
| D0240 | <1% | 92 | $1K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 44 | $1K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 546 | $1K |
| 80143 | <1% | 118 | $1K | |
| 80179 | <1% | 109 | $1K | |
| 74022 | <1% | 19 | $958.12 | |
| 84100 | <1% | 338 | $895.16 | |
| 83615 | <1% | 235 | $863.46 | |
| 83540 | <1% | 299 | $858.29 | |
| 97162 | <1% | 21 | $851.23 | |
| 82247 | <1% | 224 | $838.05 | |
| 76000 | <1% | 19 | $824.58 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,083 | $823.16 |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $782.84 |
| 94010 | <1% | 13 | $730.65 | |
| 70498 | <1% | 13 | $697.80 | |
| 76376 | <1% | 4,401 | $596.66 | |
| 97010 | <1% | 156 | $586.91 | |
| 36600 | <1% | 13 | $546.37 | |
| 93922 | <1% | 14 | $542.25 | |
| J2704 | Injection, propofol, 10 mg | <1% | 4,907 | $524.06 |
| 85045 | <1% | 200 | $494.60 | |
| 73552 | <1% | 12 | $458.41 | |
| 86592 | <1% | 185 | $439.72 | |
| 84550 | <1% | 145 | $423.78 | |
| D2331 | <1% | 30 | $418.68 | |
| 84156 | <1% | 158 | $397.60 | |
| 73060 | <1% | 12 | $379.38 | |
| 86703 | <1% | 27 | $283.52 | |
| 96376 | <1% | 2,610 | $212.95 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,394 | $209.19 |
| 94664 | <1% | 1,545 | $180.53 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15 | $173.20 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,824 | $138.15 |
| 82150 | <1% | 43 | $135.34 | |
| 86038 | <1% | 15 | $119.68 | |
| 84520 | <1% | 40 | $118.81 | |
| C1769 | Guide wire | <1% | 1,268 | $118.48 |
| 83550 | <1% | 41 | $113.68 | |
| 87081 | <1% | 50 | $88.06 | |
| 89051 | <1% | 15 | $49.49 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 4,485 | $47.95 |
| 82272 | <1% | 18 | $45.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 10,081 | $42.31 |
| 90715 | <1% | 323 | $40.11 | |
| 82570 | <1% | 14 | $35.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,028 | $32.55 |
| 84157 | <1% | 14 | $32.27 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,763 | $25.32 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,898 | $23.94 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 195 | $23.70 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,343 | $22.54 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 46 | $21.22 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 324 | $19.75 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 26 | $19.10 |
| 84145 | <1% | 1,352 | $16.32 | |
| 85014 | <1% | 20 | $13.53 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 44 | $10.59 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 781 | $6.97 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,376 | $6.48 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 432 | $6.22 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,251 | $2.91 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,711 | $2.11 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 192 | $1.40 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 49 | $0.90 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 969 | $0.31 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 972 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 1,695 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 138 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 797 | $0.00 |
| 94761 | 0% | 3,635 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 230 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 17 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 274 | $0.00 |
| 0240U | 0% | 270 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 126 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 12 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 141 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 76 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 80 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 86 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 21 | $0.00 |
| 80050 | General health panel | 0% | 40 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 31 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 18 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 18 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 772 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 1,083 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 110 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 172 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 796 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 71 | $0.00 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 0% | 163 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 145 | $0.00 |
| 99152 | 0% | 209 | $0.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 128 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 342 | $0.00 |
| T5999 | Supply, not otherwise specified | 0% | 37 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 18 | $0.00 |
| 76937 | 0% | 28 | $0.00 | |
| 94729 | 0% | 15 | $0.00 | |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 0% | 18 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.